ClinVar Genomic variation as it relates to human health
NM_005591.4(MRE11):c.630G>C (p.Trp210Cys)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_005591.4(MRE11):c.630G>C (p.Trp210Cys)
Variation ID: 8786 Accession: VCV000008786.11
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 11q21 11: 94476318 (GRCh38) [ NCBI UCSC ] 11: 94209484 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Oct 14, 2016 Sep 16, 2024 Mar 17, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_005591.4:c.630G>C MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_005582.1:p.Trp210Cys missense NM_001330347.2:c.630G>C NP_001317276.1:p.Trp210Cys missense NM_005590.4:c.630G>C NP_005581.2:p.Trp210Cys missense NC_000011.10:g.94476318C>G NC_000011.9:g.94209484C>G NG_007261.1:g.22557G>C LRG_85:g.22557G>C LRG_85t1:c.630G>C LRG_85p1:p.Trp210Cys - Protein change
- W210C
- Other names
- -
- Canonical SPDI
- NC_000011.10:94476317:C:G
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
MRE11 | - | - |
GRCh38 GRCh37 |
2145 | 2181 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic/Likely pathogenic (5) |
criteria provided, multiple submitters, no conflicts
|
Mar 17, 2024 | RCV000009331.14 | |
Pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
Feb 2, 2024 | RCV000712327.4 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Jun 30, 2016)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Athena Diagnostics
Accession: SCV000842797.1
First in ClinVar: Oct 20, 2018 Last updated: Oct 20, 2018 |
|
|
Likely pathogenic
(Sep 04, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Ataxia-telangiectasia-like disorder 1
Affected status: unknown
Allele origin:
germline
|
Revvity Omics, Revvity
Accession: SCV002023515.3
First in ClinVar: Nov 29, 2021 Last updated: Feb 04, 2024 |
|
|
Pathogenic
(Jan 17, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
Ataxia-telangiectasia-like disorder 1
Affected status: yes
Allele origin:
unknown
|
Baylor Genetics
Accession: SCV001520878.1
First in ClinVar: Mar 22, 2021 Last updated: Mar 22, 2021 |
Comment:
This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868].
|
|
Pathogenic
(Mar 17, 2024)
|
criteria provided, single submitter
Method: research
|
Ataxia-telangiectasia-like disorder 1
Affected status: unknown
Allele origin:
germline
|
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center
Accession: SCV004805146.2
First in ClinVar: Mar 30, 2024 Last updated: Apr 06, 2024 |
|
|
Pathogenic
(Feb 02, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV005201979.1
First in ClinVar: Sep 16, 2024 Last updated: Sep 16, 2024 |
Comment:
Published functional studies suggest the p.(W210C) variant results in slightly lower nuclease activity, diminishes the interaction with Nbs1, and has similar sensitivity to DNA damage … (more)
Published functional studies suggest the p.(W210C) variant results in slightly lower nuclease activity, diminishes the interaction with Nbs1, and has similar sensitivity to DNA damage when compared to wildtype (PMID: 22078559, 22705791, 23080121, 23388631); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 35048780, 31908056, 18652530, 15574463, 22705791, 31033087, 37808486, 23388631, 21324166, 22078559, 23080121, 32668560, 27124789, 17674145, 21035407, 18568480, 16189143, 31130284, 18083591) (less)
|
|
Pathogenic
(Sep 26, 2019)
|
no assertion criteria provided
Method: clinical testing
|
Ataxia-telangiectasia-like disorder 1
Affected status: yes
Allele origin:
germline
|
Biochemical Molecular Genetic Laboratory, King Abdulaziz Medical City
Accession: SCV001133231.1
First in ClinVar: Jan 04, 2020 Last updated: Jan 04, 2020 |
|
|
Pathogenic
(Jan 15, 2005)
|
no assertion criteria provided
Method: literature only
|
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000029549.4
First in ClinVar: Apr 04, 2013 Last updated: Jan 16, 2020 |
Comment on evidence:
In 10 patients from 3 unrelated Saudi Arabian families with ataxia-telangiectasia-like disorder-1 (ATLD1; 604391), Fernet et al. (2005) identified homozygosity for a 630G-C transversion in … (more)
In 10 patients from 3 unrelated Saudi Arabian families with ataxia-telangiectasia-like disorder-1 (ATLD1; 604391), Fernet et al. (2005) identified homozygosity for a 630G-C transversion in exon 7 of the MRE11A gene, resulting in a trp210-to-cys (W210C) substitution between motifs III and IV of the N-terminal nuclease domain. Patients presented with an early-onset, slowly progressive, ataxia plus ocular apraxia phenotype with an absence of tumor development, even in the oldest 37-year-old patient. Extraneurologic features, such as telangiectasia, raised alpha-fetoprotein, and reduced immunoglobulin levels, were absent. (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Clinical genomics can facilitate countrywide estimation of autosomal recessive disease burden. | Abouelhoda M | Genetics in medicine : official journal of the American College of Medical Genetics | 2016 | PMID: 27124789 |
Mre11 ATLD17/18 mutation retains Tel1/ATM activity but blocks DNA double-strand break repair. | Limbo O | Nucleic acids research | 2012 | PMID: 23080121 |
Structure of Mre11-Nbs1 complex yields insights into ataxia-telangiectasia-like disease mutations and DNA damage signaling. | Schiller CB | Nature structural & molecular biology | 2012 | PMID: 22705791 |
Crystal structure of human Mre11: understanding tumorigenic mutations. | Park YB | Structure (London, England : 1993) | 2011 | PMID: 22078559 |
Clinical and molecular characterization of ataxia with oculomotor apraxia patients in Saudi Arabia. | Bohlega SA | BMC medical genetics | 2011 | PMID: 21324166 |
Assessment of carriers' frequency of a novel MRE11 mutation responsible for the rare ataxia telangiectasia-like disorder. | Alsbeih G | Genetic testing | 2008 | PMID: 18652530 |
Identification and functional consequences of a novel MRE11 mutation affecting 10 Saudi Arabian patients with the ataxia telangiectasia-like disorder. | Fernet M | Human molecular genetics | 2005 | PMID: 15574463 |
Text-mined citations for rs137852763 ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.